hydroxyitraconazole has been researched along with fumarates in 1 studies
| Studies (hydroxyitraconazole) | Trials (hydroxyitraconazole) | Recent Studies (post-2010) (hydroxyitraconazole) | Studies (fumarates) | Trials (fumarates) | Recent Studies (post-2010) (fumarates) |
|---|---|---|---|---|---|
| 87 | 29 | 22 | 4,655 | 342 | 1,823 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backman, JT; Kurkinen, KJ; Neuvonen, PJ; Niemi, M; Tapaninen, T | 1 |
1 trial(s) available for hydroxyitraconazole and fumarates
| Article | Year |
|---|---|
Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren.
Topics: Adult; Amides; Antifungal Agents; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Fumarates; Half-Life; Humans; Itraconazole; Male; Metabolic Clearance Rate; Renin; Young Adult | 2011 |